Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Astrazeneca (AZNCF) Return on Assets (2016 - 2025)

Historic Return on Assets for Astrazeneca (AZNCF) over the last 17 years, with Q4 2025 value amounting to 0.11%.

  • Astrazeneca's Return on Assets rose 300.0% to 0.11% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.11%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.11% for FY2025, which is 300.0% up from last year.
  • Astrazeneca's Return on Assets amounted to 0.11% in Q4 2025, which was up 300.0% from 0.1% recorded in Q3 2025.
  • Over the past 5 years, Astrazeneca's Return on Assets peaked at 0.11% during Q4 2025, and registered a low of 0.03% during Q1 2022.
  • Over the past 5 years, Astrazeneca's median Return on Assets value was 0.07% (recorded in 2023), while the average stood at 0.05%.
  • Per our database at Business Quant, Astrazeneca's Return on Assets plummeted by -1000bps in 2022 and then soared by 800bps in 2023.
  • Quarter analysis of 5 years shows Astrazeneca's Return on Assets stood at 0.0% in 2021, then soared by 631bps to 0.03% in 2022, then surged by 167bps to 0.07% in 2023, then grew by 19bps to 0.08% in 2024, then soared by 30bps to 0.11% in 2025.
  • Its Return on Assets stands at 0.11% for Q4 2025, versus 0.1% for Q3 2025 and 0.09% for Q2 2025.